UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee

The American journal of gastroenterology, 2010-03, Vol.105 (3), p.501-523

2010

Link zum Volltext

Verfügbarkeit prüfen

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

The New England journal of medicine, 2010-04, Vol.362 (15), p.1383-1395

2010

Link zum Volltext

Verfügbarkeit prüfen

Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort Study

Gastroenterology (New York, N.Y. 1943), 2007-10, Vol.133 (4), p.1099-1105

2007

Link zum Volltext

Verfügbarkeit prüfen

Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee

The American journal of gastroenterology, 2004-07, Vol.99 (7), p.1371-1385

2004

Link zum Volltext

Verfügbarkeit prüfen

The Risk of Retention of the Capsule Endoscope in Patients with Known or Suspected Crohn's Disease

The American journal of gastroenterology, 2006-10, Vol.101 (10), p.2218-2222

2006

Link zum Volltext

Verfügbarkeit prüfen

Relapses of Inflammatory Bowel Disease During Pregnancy: In-Hospital Management and Birth Outcomes

The American journal of gastroenterology, 2008-05, Vol.103 (5), p.1203-1209

2008

Link zum Volltext

Verfügbarkeit prüfen

Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy

The New England journal of medicine, 1994-06, Vol.330 (26), p.1841-1845

1994

Link zum Volltext

Verfügbarkeit prüfen

Do Guidelines Matter? Implementation of the ACG and AGA Osteoporosis Screening Guidelines in Inflammatory Bowel Disease (IBD) Patients Who Meet the Guidelines' Criteria

The American journal of gastroenterology, 2006-07, Vol.101 (7), p.1546-1550

2006

Link zum Volltext

Verfügbarkeit prüfen

Management of Inflammatory Bowel Disease and COVID-19 in New York City 2020: The Epicenter of IBD in the First Epicenter of the Global Pandemic

Inflammatory bowel diseases, 2020-11, Vol.26 (11), p.1779-1785

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

Gut, 2014-01, Vol.63 (1), p.88-95

2014

Link zum Volltext

Verfügbarkeit prüfen

Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence

Inflammatory bowel diseases, 2011-02, Vol.17 (2), p.599-604

2011

Link zum Volltext

Verfügbarkeit prüfen

Validation of Endoscopic Activity Scores in Patients With Crohn's Disease Based on a Post Hoc Analysis of Data From SONIC

Gastroenterology (New York, N.Y. 1943), 2013-11, Vol.145 (5), p.978-986.e5

2013

Link zum Volltext

Verfügbarkeit prüfen

Factors Associated With Short- and Long-Term Outcomes of Therapy for Crohn’s Disease

Clinical gastroenterology and hepatology, 2015-03, Vol.13 (3), p.539-547.e2

2015

Link zum Volltext

Verfügbarkeit prüfen

Adjustable Intragastric Balloons: A 12-Month Pilot Trial in Endoscopic Weight Loss Management

Obesity surgery, 2011-10, Vol.21 (10), p.1499-1507

2011

Link zum Volltext

Verfügbarkeit prüfen

Progression to Colorectal Neoplasia in Ulcerative Colitis: Effect of Mesalamine

Clinical gastroenterology and hepatology, 2008-11, Vol.6 (11), p.1225-1230

2008

Link zum Volltext

Verfügbarkeit prüfen

Delayed-Release Oral Mesalamine at 4.8 g day (800 mg tablet) for the Treatment of Moderately Active Ulcerative Colitis: The ASCEND II Trial

The American journal of gastroenterology, 2005-11, Vol.100 (11), p.2478-2485

2005

Link zum Volltext

Verfügbarkeit prüfen

Teduglutide, a novel mucosally active analog of glucagon‐like peptide‐2 (GLP‐2) for the treatment of moderate to severe Crohn's disease

Inflammatory bowel diseases, 2010-06, Vol.16 (6), p.962-973

2010

Link zum Volltext

Verfügbarkeit prüfen

Change in erythrocyte mean corpuscular volume during combination therapy with azathioprine and infliximab is associated with mucosal healing: a post hoc analysis from SONIC

Inflammatory bowel diseases, 2015-03, Vol.21 (3), p.606-614

2015

Link zum Volltext

Verfügbarkeit prüfen

Adverse Events Associated With the Use of Cyclosporine in Patients With Inflammatory Bowel Disease

The American journal of gastroenterology, 2008-04, Vol.103 (4), p.937-943

2008

Link zum Volltext

Verfügbarkeit prüfen

Does Hormonal Therapy Have Any Benefit for Bleeding Angiodysplasia?

Journal of clinical gastroenterology, 1992-09, Vol.15 (2), p.99-103

1992

Link zum Volltext

Verfügbarkeit prüfen

A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease

Gut, 2010-06, Vol.59 (6), p.760-766

2010

Link zum Volltext

Verfügbarkeit prüfen

Treatment responses in collagenous colitis

The American journal of gastroenterology, 2001-03, Vol.96 (3), p.818-821

2001

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Ulcerative Colitis with Fish Oil n-3-ω-Fatty Acid: An Open Trial

Journal of clinical gastroenterology, 1990-04, Vol.12 (2), p.157-161

1990

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis

The American journal of gastroenterology, 2002-10, Vol.97 (10), p.2577-2584

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Humans
(28)
Life Sciences & Biomedicine
(27)
Science & Technology
(27)
Female
(26)
Male
(25)
Gastroenterology & Hepatology
(24)
Middle Aged
(16)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Gastroenterology
(11)
Gastroenterology. Liver. Pancreas. Abdomen
(11)
Other Diseases. Semiology
(11)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(11)
Aged
(10)
Crohn Disease - Drug Therapy
(9)
Treatment Outcome
(9)
Adolescent
(8)
Azathioprine - Therapeutic Use
(6)
Cohort Studies
(6)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort Study

Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee

The Risk of Retention of the Capsule Endoscope in Patients with Known or Suspected Crohn's Disease

Relapses of Inflammatory Bowel Disease During Pregnancy: In-Hospital Management and Birth Outcomes

Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy

Do Guidelines Matter? Implementation of the ACG and AGA Osteoporosis Screening Guidelines in Inflammatory Bowel Disease (IBD) Patients Who Meet the Guidelines' Criteria

Management of Inflammatory Bowel Disease and COVID-19 in New York City 2020: The Epicenter of IBD in the First Epicenter of the Global Pandemic

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice

Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence

Validation of Endoscopic Activity Scores in Patients With Crohn's Disease Based on a Post Hoc Analysis of Data From SONIC

Factors Associated With Short- and Long-Term Outcomes of Therapy for Crohn’s Disease

Adjustable Intragastric Balloons: A 12-Month Pilot Trial in Endoscopic Weight Loss Management

Progression to Colorectal Neoplasia in Ulcerative Colitis: Effect of Mesalamine

Delayed-Release Oral Mesalamine at 4.8 g day (800 mg tablet) for the Treatment of Moderately Active Ulcerative Colitis: The ASCEND II Trial

Teduglutide, a novel mucosally active analog of glucagon‐like peptide‐2 (GLP‐2) for the treatment of moderate to severe Crohn's disease

Change in erythrocyte mean corpuscular volume during combination therapy with azathioprine and infliximab is associated with mucosal healing: a post hoc analysis from SONIC

Adverse Events Associated With the Use of Cyclosporine in Patients With Inflammatory Bowel Disease

Does Hormonal Therapy Have Any Benefit for Bleeding Angiodysplasia?

A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease

Treatment responses in collagenous colitis

Treatment of Ulcerative Colitis with Fish Oil n-3-ω-Fatty Acid: An Open Trial

Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis

Aktive Filter

Suchergebnisse filtern